NM_020987.5:c.9368A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_020987.5(ANK3):​c.9368A>G​(p.Lys3123Arg) variant causes a missense change. The variant allele was found at a frequency of 0.242 in 1,613,926 control chromosomes in the GnomAD database, including 51,397 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.19 ( 3381 hom., cov: 32)
Exomes 𝑓: 0.25 ( 48016 hom. )

Consequence

ANK3
NM_020987.5 missense

Scores

3
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 4.62

Publications

23 publications found
Variant links:
Genes affected
ANK3 (HGNC:494): (ankyrin 3) Ankyrins are a family of proteins that are believed to link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact, and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 3 is an immunologically distinct gene product from ankyrins 1 and 2, and was originally found at the axonal initial segment and nodes of Ranvier of neurons in the central and peripheral nervous systems. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
ANK3 Gene-Disease associations (from GenCC):
  • intellectual disability-hypotonia-spasticity-sleep disorder syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • intellectual disability
    Inheritance: AR, AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
  • Tourette syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.001493752).
BP6
Variant 10-60071513-T-C is Benign according to our data. Variant chr10-60071513-T-C is described in ClinVar as Benign. ClinVar VariationId is 128385.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.263 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANK3NM_020987.5 linkc.9368A>G p.Lys3123Arg missense_variant Exon 37 of 44 ENST00000280772.7 NP_066267.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANK3ENST00000280772.7 linkc.9368A>G p.Lys3123Arg missense_variant Exon 37 of 44 1 NM_020987.5 ENSP00000280772.1

Frequencies

GnomAD3 genomes
AF:
0.187
AC:
28427
AN:
152056
Hom.:
3380
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0490
Gnomad AMI
AF:
0.251
Gnomad AMR
AF:
0.214
Gnomad ASJ
AF:
0.206
Gnomad EAS
AF:
0.0368
Gnomad SAS
AF:
0.159
Gnomad FIN
AF:
0.248
Gnomad MID
AF:
0.205
Gnomad NFE
AF:
0.267
Gnomad OTH
AF:
0.191
GnomAD2 exomes
AF:
0.204
AC:
51224
AN:
251240
AF XY:
0.208
show subpopulations
Gnomad AFR exome
AF:
0.0441
Gnomad AMR exome
AF:
0.161
Gnomad ASJ exome
AF:
0.209
Gnomad EAS exome
AF:
0.0359
Gnomad FIN exome
AF:
0.250
Gnomad NFE exome
AF:
0.269
Gnomad OTH exome
AF:
0.234
GnomAD4 exome
AF:
0.248
AC:
362857
AN:
1461752
Hom.:
48016
Cov.:
38
AF XY:
0.246
AC XY:
178891
AN XY:
727192
show subpopulations
African (AFR)
AF:
0.0402
AC:
1347
AN:
33472
American (AMR)
AF:
0.167
AC:
7466
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.209
AC:
5450
AN:
26130
East Asian (EAS)
AF:
0.0493
AC:
1957
AN:
39700
South Asian (SAS)
AF:
0.157
AC:
13576
AN:
86252
European-Finnish (FIN)
AF:
0.255
AC:
13632
AN:
53418
Middle Eastern (MID)
AF:
0.224
AC:
1291
AN:
5764
European-Non Finnish (NFE)
AF:
0.274
AC:
304381
AN:
1111916
Other (OTH)
AF:
0.228
AC:
13757
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
16486
32972
49457
65943
82429
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9908
19816
29724
39632
49540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.187
AC:
28431
AN:
152174
Hom.:
3381
Cov.:
32
AF XY:
0.187
AC XY:
13935
AN XY:
74414
show subpopulations
African (AFR)
AF:
0.0488
AC:
2029
AN:
41538
American (AMR)
AF:
0.214
AC:
3271
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.206
AC:
714
AN:
3468
East Asian (EAS)
AF:
0.0375
AC:
194
AN:
5178
South Asian (SAS)
AF:
0.160
AC:
770
AN:
4824
European-Finnish (FIN)
AF:
0.248
AC:
2630
AN:
10588
Middle Eastern (MID)
AF:
0.207
AC:
60
AN:
290
European-Non Finnish (NFE)
AF:
0.267
AC:
18134
AN:
67988
Other (OTH)
AF:
0.189
AC:
400
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1132
2264
3397
4529
5661
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
304
608
912
1216
1520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.242
Hom.:
20881
Bravo
AF:
0.177
TwinsUK
AF:
0.264
AC:
980
ALSPAC
AF:
0.290
AC:
1116
ESP6500AA
AF:
0.0513
AC:
226
ESP6500EA
AF:
0.261
AC:
2244
ExAC
AF:
0.202
AC:
24505
Asia WGS
AF:
0.0890
AC:
313
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Intellectual disability-hypotonia-spasticity-sleep disorder syndrome Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.097
BayesDel_addAF
Benign
-0.63
T
BayesDel_noAF
Benign
-0.54
CADD
Benign
23
DANN
Benign
0.094
DEOGEN2
Benign
0.23
T
Eigen
Benign
-0.49
Eigen_PC
Benign
-0.24
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Uncertain
0.92
D
MetaRNN
Benign
0.0015
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-0.11
N
PhyloP100
4.6
PrimateAI
Uncertain
0.60
T
PROVEAN
Benign
0.54
N
REVEL
Benign
0.094
Sift
Benign
0.81
T
Polyphen
0.0010
B
Vest4
0.18
MPC
0.54
ClinPred
0.0096
T
GERP RS
5.2
Varity_R
0.051
gMVP
0.15
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10821668; hg19: chr10-61831271; COSMIC: COSV55051103; COSMIC: COSV55051103; API